News & Updates
Filter by Specialty:
Chemo-induced nausea, vomiting? There’s a dexamethasone-free regimen for that
A dexamethasone-free regimen helps improve control of nausea and vomiting in patients receiving “highly emetogenic” chemotherapy, with the antiemetic effect being superior to that of a dexamethasone-based regimen, according to the results of a phase III trial presented at ASCO Breakthrough 2023.
Chemo-induced nausea, vomiting? There’s a dexamethasone-free regimen for that
28 Aug 2023
QoL preserved in patients with refractory mCRC treated with add-on bevacizumab
In the treatment of refractory metastatic colorectal cancer (mCRC), the addition of bevacizumab to trifluridine/tipiracil (FTD/TPI) does not appear to hurt the quality of life (QoL), with patients receiving add-on bevacizumab being able to maintain their QoL for a longer period than those receiving FTD/TPI monotherapy, according to a post hoc analysis of the phase III SUNLIGHT trial.
QoL preserved in patients with refractory mCRC treated with add-on bevacizumab
26 Aug 2023
Add-on esketamine beneficial to patients with fluctuating antidepressant response
A single dose of esketamine appears to enhance the efficacy of oral antidepressants for treating patients with major depressive disorder (MDD) who are experiencing fluctuating symptoms, as reported in a small study.
Add-on esketamine beneficial to patients with fluctuating antidepressant response
24 Aug 2023
Acute sinusitis in kids: Bacterial testing may curb antibiotic use
Antibiotics do little in the absence of bacterial pathogens in the nasopharynx of children with acute sinusitis, according to a study, suggesting that testing for specific bacteria on presentation may help prevent unnecessary antibiotic use.
